Lam Research Corporation (LRCX) Stock Price Today
Key Stats
- $368.64BMarket Cap
- -Volume
- TechnologySector
- $433.3352W High
- $95.9452W Low
- -Typical Hold Time
- $366.79BEnterprise Value
- 0.35%Div Yield
- -Trading Activity
Track Lam Research Corporation (LRCX) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, Lam Research Corporation has traded between a low of $95.94 and a high of $433.33, highlighting its annual price range. Buy and sell Lam Research Corporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About Lam Research Corporation
Lam Research manufactures equipment used to fabricate semiconductors. The firm is focused on the etching, deposition, and clean markets, which are key steps in the semiconductor manufacturing process, especially for 3D NAND flash storage, advanced DRAM, and leading-edge logic/foundry chipmakers. Lam's flagship Kiyo, Vector, and Sabre products are sold in all major geographies to key customers such as Samsung Electronics, Micron, Intel, and Taiwan Semiconductor Manufacturing.
Most Recent News
Bunge Global SA gains insider buy and analyst boost, with price target up 28%
Bunge Global SA saw a director purchase 1,500 shares at $107.60, signaling insider confidence. Analysts have set a mean price target of $138.30, implying a 28.3% upside, driven by strong Q2 performance in soybeans and softseeds that raised earnings o...

Stocks plunge amid inverse ETF drops, legal probes, and earnings worries.
Stocks fell sharply due to various factors including a 58.71% drop in the Defiance Daily Target 2x Short PLTR ETF, driven by strong gains in Palantir Technologies, which the ETF inversely tracks. AdaptHealth shares dropped 38.09% amid a legal investi...

Law firm probes Karyopharm over executive retention bonuses amid stock price drop
Pomerantz LLP is investigating Karyopharm Therapeutics for potential securities fraud related to a retention program granting top executives lump sum cash bonuses between $625,000 and $1,725,000. The announcement led to a 21.45% drop in Karyopharm's ...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.